Agrawal Medicaments Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 03-07-2024
- Company Age 12 Year, 12 Days
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2015)
- Profit -22403.56%
(FY 2015)
- Ebitda -22274.72%
(FY 2015)
- Net Worth -5468.03%
(FY 2015)
- Total Assets 276.99%
(FY 2015)
About Agrawal Medicaments
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Krishnakumar Agrawal, Anirudh Agrawal, and Anurag Agrawal serve as directors at the Company.
- CIN/LLPIN
U24119GA2012PTC007117
- Company No.
007117
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2012
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
South Goa, Goa, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Agrawal Medicaments?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anirudh Agrawal  | Director | 07-Dec-2012 | Current |
| Krishnakumar Agrawal | Director | 07-Dec-2012 | Current |
| Anurag Agrawal | Director | 07-Dec-2012 | Current |
Financial Performance and Corporate Structure Insights of Agrawal Medicaments.
Agrawal Medicaments Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 22403.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 5468.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agrawal Medicaments?
In 2017, Agrawal Medicaments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kayji Real Estate Private Limited.Active 48 years 6 monthsKrishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
Dci Pharmaceuticals Private LimitedActive 48 years 11 monthsKrishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
Agrawal Minerals (Goa) Private LimitedActive 58 years 1 monthKrishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
- Aryavaan Pharmaceuticals Private LimitedActive 20 years 2 months
Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
- Medizest Pharmaceuticals Private LimitedActive 37 years 5 months
Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
- Tyresoles Goa Private LimitedActive 59 years 6 months
Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Agrawal Medicaments?
Agrawal Medicaments has a workforce of 1 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agrawal Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agrawal Medicaments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
